TFS Capital’s Merck MRK Stock Holding History

TFS Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-5,676	Closed	-$344K	–	712
2017 Q1	$344K	Buy	+5,676	New	+$344K	0.11%	348

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TFS Capital's MRK Position: Q2 2017 in Review

TFS Capital sold out of Merck (MRK) in Q2 2017, closing a stake of 5,676 shares — an estimated $344K sold.

TFS Capital first reported a position in MRK in Q1 2017 and held it in 1 quarter. The position peaked at $344K in Q1 2017. 1,925 funds tracked by Wall St. Rank hold MRK as of Q2 2017.

TFS Capital reported no remaining Merck position as of Q2 2017 after selling out during the quarter.
TFS Capital sold 5,676 Merck shares in Q2 2017, an estimated $344K.
TFS Capital first reported a position in Merck in Q1 2017 and held it in 1 quarter.
TFS Capital's Merck position peaked at $344K in Q1 2017.
1,925 funds tracked by Wall St. Rank held Merck as of Q2 2017.

Based on TFS Capital's 13F filing for Q2 2017, filed 11 Aug 2017.